BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 33261583)

  • 1. Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study.
    Qian F; Gao G; Song Y; Xu Y; Wang A; Wang S; Hao Y; Chen M; Ma X; Zhao T; Guo X; Chen Z; Zhang F
    BMC Infect Dis; 2020 Dec; 20(1):910. PubMed ID: 33261583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus.
    Liu D; Lan L; Luo D; Zhao B; Wei G; He Y; Zhang R; Liu Y
    Diabetes Res Clin Pract; 2020 Sep; 167():108341. PubMed ID: 32707212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
    Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and prognostic value of peripheral blood T lymphocyte subsets in patients with severe influenza].
    Geng TR; Han Y; Qiu ZF; Du TK; Jiang W; Shi JH; Qin T; Fan HW; Li TS
    Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):200-206. PubMed ID: 32146746
    [No Abstract]   [Full Text] [Related]  

  • 7. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
    Iannetta M; Buccisano F; Fraboni D; Malagnino V; Campogiani L; Teti E; Spalliera I; Rossi B; Di Lorenzo A; Palmieri R; Crea A; Zordan M; Vitale P; Voso MT; Andreoni M; Sarmati L
    Sci Rep; 2021 Jun; 11(1):12762. PubMed ID: 34140530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.
    Li Q; Xu W; Li WX; Huang CL; Chen L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12536-12544. PubMed ID: 33336774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19.
    Deng Z; Zhang M; Zhu T; Zhili N; Liu Z; Xiang R; Zhang W; Xu Y
    Int J Infect Dis; 2020 Sep; 98():353-358. PubMed ID: 32634585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.
    Zhang P; Du W; Yang T; Zhao L; Xiong R; Li Y; Geng Y; Lu W; Zhou J
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048567. PubMed ID: 34619994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
    Ni M; Tian FB; Xiang DD; Yu B
    J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019.
    Meng L; Xu J; Zhang J; Zhang K; Shang P; Li Q; Li Y; Wang L; Cai B
    Aging (Albany NY); 2021 Mar; 13(6):7723-7732. PubMed ID: 33741750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of peripheral lymphocyte subsets and T-cell exhaustion in SARS-CoV-2 Infection.
    Soyyiğit Ş; Öksüzer Çimşir D; Öncül A; Pekel A; Öner Erkekol F; Güner R; İzdeş S; Gökmen D; Gökbulut Bektaş Ş; İnan O; Gemcioğlu E; Yılmaz A; Şahiner ES; Hasanoğlu İ; Kaya Kalem A; Kayaaslan B; Eser F; Ateş İ
    Tuberk Toraks; 2024 Jun; 72(2):152-166. PubMed ID: 38869208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappearance of effector T cells is associated with recovery from COVID-19.
    Odak I; Barros-Martins J; Bošnjak B; Stahl K; David S; Wiesner O; Busch M; Hoeper MM; Pink I; Welte T; Cornberg M; Stoll M; Goudeva L; Blasczyk R; Ganser A; Prinz I; Förster R; Koenecke C; Schultze-Florey CR
    EBioMedicine; 2020 Jul; 57():102885. PubMed ID: 32650275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of memory T cells in COVID-19 patients and the predictive role of CD4+CD8+ double positive T lymphocytes as a new marker.
    Kalpakci Y; Hacibekiroglu T; Trak G; Karacaer C; Demirci T; Kocayigit H; Sunu C; Varim C; Falay M
    Rev Assoc Med Bras (1992); 2020 Dec; 66(12):1666-1672. PubMed ID: 33331574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and predictive value of lower CD4
    Wen XS; Jiang D; Gao L; Zhou JZ; Xiao J; Cheng XC; He B; Chen Y; Lei P; Tan XW; Qin S; Zhang DY
    BMC Infect Dis; 2021 Jan; 21(1):57. PubMed ID: 33435865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the changes of the T-lymphocyte subsets and their significance in influenza A (H1N1) virus patients].
    Zhang SP; Zhu ML; Yu JH; Wang Y; Lou GQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):181-3. PubMed ID: 21186520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent High Percentage of HLA-DR
    Du J; Wei L; Li G; Hua M; Sun Y; Wang D; Han K; Yan Y; Song C; Song R; Zhang H; Han J; Liu J; Kong Y
    Front Immunol; 2021; 12():735125. PubMed ID: 34567001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
    Reche PA
    Front Immunol; 2020; 11():586984. PubMed ID: 33178220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.